HIV Drugs No Longer in Development

Overview

Failed Anti-HIV Drugs (Regularly Updated)
From aidsmap.com

Capravirine

Pfizer Drops Development of Antiretroviral Capravirine, Citing Lack of Efficacy in Trials (July 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Pfizer Discontinues Development of Capravirine, for HIV/AIDS (July 1, 2005)
From Pfizer, Inc.

Lodenosine

Lodenosine Update (March 2000)
In What's New, from Project Inform
Safety Concerns Prompt Suspension of Lodenosine Clinical Trial (December 1999/January 2000)
In Positive Living, from AIDS Project Los Angeles
Lodenosine Study Suspended (October 1999)
In HIV Newsline, from San Francisco General Hospital

Othe Drugs

Incyte Halts Development of Promising New CCR5 Drug (April 10, 2008)
From Project Inform
GSK Discontinues Clinical Development of Investigational Protease Inhibitor Brecanavir (640385) (December 18, 2006)
To read PDF, click here.
From GlaxoSmithKline
Development of DFC, an Investigational NRTI, Is Discontinued (April 4, 2006)
From TheBody.com

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's App for iPhones
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.